Table 1 Univariate analysis of the prognosis of 28 patients with cervical oesophageal cancer who underwent surgery.

Gender

0.744

  Male

21

25.0 (1.1–49.0)

40.6%

  Female

7

16.0

50.0%

Age(years)

0.638

  ≤60

19

18.0 (3.4–32.6)

41.2%

  >60

9

39.0 (8.2–69.8)

42.9%

Tumour length

0.102

  ≤4 cm

15

24.0 (9.0–39.0)

0%

  >4 cm

13

97.0

61.1%

Tumour cell differentiation

0.107

  Well

11

—

77.8%

  Moderate

12

24.0 (13.9–34.1)

27.3%

  Poor

5

15.0 (6.4–23.6)

20.0%

pT category

0.917

  pT_1–2

7

39.0 (6.2–71.8)

30.0%

  pT_3–4

21

25.0 (0.0–100.0)

46.3%

pN category

0.389

  pN₀

14

24.0 (10.0–38.0)

32.3%

  pN₁

14

97.0 (0.0–206.0)

55.4%

pTNM stage

0.259

  I + II

10

24.0 (14.4–33.6)

16.9%

  III

18

97.0 (0.0–254.7)

57.9%

Surgical procedure

0.417

  Transhiatal

15

18.0 (8.5–27.5)

40.0%

  Thoracoscopy

13

39.0 (14.8–63.2)

30.0%

Salvage surgery

0.007

  Yes

8

15.0 (10.5–19.5)

0%

  No

20

97.0 (0.1–193.9)

54.0%